Shanghai | China
| Investor Type | Firm |
| Type of Fund | Other |
| Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Aerospace (& Defense) • Life Science • Oncology |
| Stages | MBO/LBO, Turnaround, Recapitalization, Corporate Divestiture,Early |
| Investing | United States • China |
| Investment Range | $58,060,000 - $58,060,000 |
| Assets Under Management | $50,000,000 |
About The Fund
Decheng Capital is an investment firm that specializes in providing capital and strategic support to early-stage life science companies with revolutionary technologies as well as growth-stage healthcare companies with strong market presence. Established in 2012 and headquartered in Shanghai, China, Decheng Capital operates with a focus on various industries such as Software, IT, Education, BioTech, Business Solutions, FinTech, Hardware, Logistics, Medical Devices, Aerospace, Life Science, and Oncology. Their investment approach is characterized by a blend of expertise in Equity, with specialties in MBO/LBO, Turnaround, Recapitalization, Corporate Divestiture, and Early-stage investments. With a clear investment thesis that targets both early and growth stages within the healthcare sector, Decheng Capital manages assets with a value of $2.1 billion. Their investment size generally holds at around $58,060,000, both as a minimum and a maximum figure, demonstrating their commitment to substantial, strategic investments. Decheng Capital's team of dedicated professionals combines complementary expertise to build highly successful companies on a global scale. Thanks to a historic opportunity presented by the rapid growth of the healthcare industry and breakthroughs in life science research, Decheng positions itself as a preferred partner for entrepreneurs, world-class scientists, and strategic partners. As they aim to create value for their investors and entrepreneurial partners, Decheng has garnered support from prestigious limited partners worldwide. Their impact is highlighted by significant deals and company growth announcements in the life science and healthcare spaces, ensuring Decheng Capital's prominent role in shaping the future of these industries.
Decheng Capital's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
